These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 14719089

  • 1. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 2. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.
    Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R.
    Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593
    [Abstract] [Full Text] [Related]

  • 3. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 4. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R.
    Prostate; 2002 Nov 01; 53(3):211-7. PubMed ID: 12386921
    [Abstract] [Full Text] [Related]

  • 5. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R.
    Carcinogenesis; 2004 Sep 01; 25(9):1711-20. PubMed ID: 15117815
    [Abstract] [Full Text] [Related]

  • 6. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
    Wigington DP, Urben CM, Strugnell SA, Knutson JC.
    Anticancer Res; 2004 Sep 01; 24(5A):2905-12. PubMed ID: 15517895
    [Abstract] [Full Text] [Related]

  • 7. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 01; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 8. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K, Kaminski R, Legat M, Kopec M, Nowis D, Skierski JS, Koronkiewicz M, Jakóbisiak M, Golab J.
    Int J Oncol; 2004 May 01; 24(5):1149-57. PubMed ID: 15067336
    [Abstract] [Full Text] [Related]

  • 9. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R.
    Cancer Res; 2000 Apr 01; 60(7):2040-8. PubMed ID: 10766196
    [Abstract] [Full Text] [Related]

  • 10. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S, Agarwal P, Glode LM, Agarwal R.
    Int J Cancer; 2003 Sep 20; 106(5):699-705. PubMed ID: 12866029
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1975-9. PubMed ID: 19080259
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.
    Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R.
    J BUON; 2009 Oct 20; 14(3):479-85. PubMed ID: 19810142
    [Abstract] [Full Text] [Related]

  • 13. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 20; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 14. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY.
    Breast Cancer Res Treat; 2010 Jan 20; 119(2):255-69. PubMed ID: 19221875
    [Abstract] [Full Text] [Related]

  • 15. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
    Singh RP, Mallikarjuna GU, Sharma G, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.
    Clin Cancer Res; 2004 Dec 15; 10(24):8641-7. PubMed ID: 15623648
    [Abstract] [Full Text] [Related]

  • 16. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
    Sharma G, Singh RP, Chan DC, Agarwal R.
    Anticancer Res; 2003 Dec 15; 23(3B):2649-55. PubMed ID: 12894553
    [Abstract] [Full Text] [Related]

  • 17. Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.
    Cho YL, Christensen C, Saunders DE, Lawrence WD, Deppe G, Malviya VK, Malone JM.
    Cancer Res; 1991 Jun 01; 51(11):2848-53. PubMed ID: 2032225
    [Abstract] [Full Text] [Related]

  • 18. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.
    Cancer Res; 2002 Jun 01; 62(11):3063-9. PubMed ID: 12036915
    [Abstract] [Full Text] [Related]

  • 19. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ, Liu ZJ, Shimoi K, Zhu BT.
    Cancer Res; 2005 Jan 15; 65(2):387-93. PubMed ID: 15695378
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.